NYSE - Nasdaq Real Time Price
USD
Teva Pharmaceutical Industries Limited (TEVA)
35.27
+0.63
(+1.82%)
As of 3:14:43 PM EDT. Market Open.
Trade TEVA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for TEVA
- Previous Close
34.64 - Open
35.00 - Bid 35.36 x 20000
- Ask 35.37 x 20000
- Day's Range
34.58 - 35.47 - 52 Week Range
14.99 - 37.35 - Volume
2,641,457 - Avg. Volume
6,223,468 - Market Cap (intraday)
41.069B - Beta (5Y Monthly) 0.86
- PE Ratio (TTM)
26.32 - EPS (TTM)
1.34 - Earnings Date Jul 29, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date Nov 27, 2017
- 1y Target Est
40.90
Recent News
View More
Performance Overview
Trailing total returns as of 7/6/2026, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .
YTD Return
TEVA
13.01%
TA-125 (^TA125.TA)
13.40%
1-Year Return
TEVA
107.35%
TA-125 (^TA125.TA)
0.00%
3-Year Return
TEVA
350.45%
TA-125 (^TA125.TA)
131.35%
5-Year Return
TEVA
267.01%
TA-125 (^TA125.TA)
134.98%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 7/2/2026
-
Market Cap
40.89B
-
Enterprise Value
54.06B
-
Trailing P/E
25.85
-
Forward P/E
16.69
-
PEG Ratio (5yr expected)
0.99
-
Price/Sales (ttm)
2.33
-
Price/Book (mrq)
4.90
-
Enterprise Value/Revenue
3.10
-
Enterprise Value/EBITDA
16.43
Financial Highlights
Profitability and Income Statement
-
Profit Margin
9.02%
-
Return on Assets (ttm)
6.38%
-
Return on Equity (ttm)
21.60%
-
Revenue (ttm)
17.35B
-
Net Income Avi to Common (ttm)
1.56B
-
Diluted EPS (ttm)
1.34
Balance Sheet and Cash Flow
-
Total Cash (mrq)
3.74B
-
Total Debt/Equity (mrq)
205.60%
-
Levered Free Cash Flow (ttm)
2.61B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
35.27
+1.82%
Mkt Cap
41.069B
Industry
Drug Manufacturers—Specialty & Generic
4.2400
+1.44%
Mkt Cap
531.98M
Industry
Drug Manufacturers—Specialty & Generic
5.99
-5.99%
Mkt Cap
2.962B
Industry
Drug Manufacturers—Specialty & Generic
37.92
+3.03%
Mkt Cap
8.776B
Industry
Drug Manufacturers—Specialty & Generic
4.3755
-5.29%
Mkt Cap
540.185M
Industry
Drug Manufacturers—Specialty & Generic
16.92
+0.86%
Mkt Cap
53.447B
Industry
Drug Manufacturers—Specialty & Generic
4.7650
-2.76%
Mkt Cap
1.78B
Industry
Drug Manufacturers—Specialty & Generic
0.9704
-2.96%
Mkt Cap
435.143M
Industry
Drug Manufacturers—Specialty & Generic
2.3600
-4.07%
Mkt Cap
76.035M
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Teva Pharmaceutical Industries Ltd. is the world's largest generic pharmaceutical manufacturer, with roughly 76 billion tablets and capsules produced annually. The company has roughly 37,000 employees and over 53 manufacturing facilities across more than 33 countries. One of every 12 prescriptions in the U.S. is filled with Teva products.
Teva Pharmaceutical Industries Ltd. is the world's largest generic pharmaceutical manufacturer, with roughly 76 billion tablets and capsules produced annually. The company has roughly 37,000 employees and over 53 manufacturing facilities across more than 33 countries. One of every 12 prescriptions in the U.S. is filled with Teva products.
RatingPrice Target -
The major indices are mixed at midday on Tuesday as stocks take a breather following recent gains. The Fed rate meeting has started and new Chairman Kevin Warsh will have his debut press conference tomorrow. Crude oil is down another 3% at $77 per barrel. The yield on the 10-year note is at 4.45%. The VIX volatility index is at 16.
The major indices are mixed at midday on Tuesday as stocks take a breather following recent gains. The Fed rate meeting has started and new Chairman Kevin Warsh will have his debut press conference tomorrow. Crude oil is down another 3% at $77 per barrel. The yield on the 10-year note is at 4.45%. The VIX volatility index is at 16.
-
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
-
Teva Pharmaceutical Industries Ltd. is the world's largest generic pharmaceutical manufacturer, with roughly 76 billion tablets and capsules produced annually. The company has roughly 37,000 employees and over 53 manufacturing facilities across more than 33 countries. One of every 12 prescriptions in the U.S. is filled with Teva products.
Teva Pharmaceutical Industries Ltd. is the world's largest generic pharmaceutical manufacturer, with roughly 76 billion tablets and capsules produced annually. The company has roughly 37,000 employees and over 53 manufacturing facilities across more than 33 countries. One of every 12 prescriptions in the U.S. is filled with Teva products.
RatingPrice Target
